Total Funding
37
63
Total FundingPost-IPO Debt raised
Growth Score 37 in past quarter
0 pts
Heat Score 63 in past quarter
-1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
288726
NovelStem International is a development and commercialization company for diagnostic technology.
Eric Richman: Independant DirectorPast Role: Horizon Infusions, Director & Co-Founder- Jan Loeb: ChairmanPast Role: Keweenaw Lnd Assn CT, Director
About the Company
NovelStem International is a provider of diagnostic technology. They provide biomedical applications in developmental biology and reproductive medicine, advanced cancer research, regenerative medicine, and genetic disease modelling services.